Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Regulatory Roundup: HHS Releases a New National Vaccine Plan

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the February 2011 edition from Alfa Laval and GE Healthcare.

February 2011 Editor's Picks: Products from Alfa Laval and GE Healthcare

William Dierick is Business Development Manager at Terumo.

The application of the first piston syringes to treat medical complications was described in Roman times during the 1st century, and forms of intravenous injection and infusion began as early as 1670.

Why Syringes Continue To Dominate The Parenteral Drug Delivery Market

Deep process characterization and "lab-on-a-chip" enable SMART bioprocess design.

SMART Bioprocess Design

Angie Drakulich was editorial director of Pharmaceutical Technology.

FDA issued a draft guidance for industry on Jan. 18, 2011, about the size of beads within drug products labeled for sprinkle.

Draft Guidance Issued on Capsule Bead Size

A company's contamination-control plan is an important document designed to formalize the rationale, methods, and validation of contamination-control procedures in a manufacturing facility. The author describes the role of bioburden in the contamination-control plan.

The Role of Bioburden in the Contamination-Control Plan

Improvements in analytical techniques may call for a re-evaluation of the biopharmaceutical industry saying that "the process is the product."

What's More Important, the Process or the Product?

Dishman is giving a step further in its strategy to manufacture high potency (HiPo) Active Pharmaceutical Ingredients (APIs).

Dishman to enter high potency generics' market

Biopharmaceuticals commonly cannot be terminally sterilised, as such aseptic processing using sterilising grade filtration is essential.

The role of sterile filtration in the biopharm industry

World AIDS Day 2010 reminds us that prevention and hope can help fight the disease.